Aequus Pharmaceuticals (QB) Stock Price

0.00 (0.0%)
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Aequus Pharmaceuticals Inc (QB) AQSZF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.087 16:13:00
Open Price Low Price High Price Close Price Previous Close
0.087 0.087
Bid Price Ask Price Spread News
0.071 0.092 0.021 - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.087 USD

Aequus Pharmaceuticals (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 9.73M 111.78M 72.83M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
253.00 $ - 0.00% - -

more financials information »

Aequus Pharmaceuticals (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AQSZF Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.080.0870.0660.0726823179,2760.0078.75%
1 Month0.091650.099310.0660.073626960,854-0.00465-5.07%
3 Months0.09570.11290.0660.079518526,944-0.0087-9.09%
6 Months0.06120.11290.05030.070980328,4310.025842.16%
1 Year0.12910.13490.0450.073953230,749-0.0421-32.61%
3 Years0.14760.3560.0450.153702434,950-0.0606-41.06%
5 Years0.45820.540.0450.176978435,072-0.3712-81.01%

Aequus Pharmaceuticals (QB) Description

Aequus Pharmaceuticals Inc. is a Vancouver-based specialty pharmaceutical company focused on developing, advancing and promoting differentiated products in Canada. Aequus development pipeline focuses on enhancing delivery methods for approved drugs that are limited by non-compliance, high frequency dosing, first-pass metabolism side-effects, painful injections, or where the therapeutic profile can be improved by making an alternative delivery system available. Aequus is developing several products in neurology and psychiatry with a goal of addressing the need for improved medication adherence through enhanced delivery systems. Aequus intends to commercialize its internal programs within Canada and to establish strategic partnerships to accelerate and maximize the potential of its product candidates worldwide.

Your Recent History
Aequus Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.